Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
University of Kansas
Collaborator:
Genentech
Information provided by (Responsible Party):
University of Kansas
ClinicalTrials.gov Identifier:
NCT00491816
First received: June 22, 2007
Last updated: May 15, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |